Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01931007 · ClinicalTrials.gov registry record · Phase 1
Use of Autologous Bone Marrow Aspirate Concentrate in Painful Knee Osteoarthritis
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT01931007: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT01931007 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01931007, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
The overall goal of this study is to develop regenerative cell therapy for use in patients with osteoarthritis (OA). The primary objective of this proposal is to conduct a pilot study that assesses the safety and feasibility of using concentrated bone marrow aspirate containing MSC to treat patients with painful knee OA.
Interventions
- DRUG Sterile saline
- DRUG Autologous Bone Marrow Aspirate Concentrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01931007
The ClinicalTrials.gov registry entry for NCT01931007 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sterile saline is the first listed.
NCT01931007 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01931007 about?
NCT01931007 is a clinical study titled "Use of Autologous Bone Marrow Aspirate Concentrate in Painful Knee Osteoarthritis". The overall goal of this study is to develop regenerative cell therapy for use in patients with osteoarthritis (OA). The primary objective of this proposal is to conduct a pilot study that assesses the safety and feasibility of using concentrated bone marrow aspirate containing MSC to treat patients...
What is the current status of trial NCT01931007?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2013-08. Estimated completion is 2016-01.
What interventions are being tested in trial NCT01931007?
The interventions under investigation include: Sterile saline (DRUG), Autologous Bone Marrow Aspirate Concentrate (DRUG).
Who is sponsoring clinical trial NCT01931007?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.